{"nct_id":"NCT04211909","title":"Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2020-01-03","start_date_type":"ACTUAL","primary_completion_date":"2020-11-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}